Omega Therapeutics Stock Technical Analysis

OMGA Stock  USD 0.86  0.07  8.86%   
As of the 25th of November, Omega Therapeutics holds the Variance of 41.06, risk adjusted performance of (0.09), and Coefficient Of Variation of (807.22). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omega Therapeutics, as well as the relationship between them.

Omega Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Omega, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Omega
  
Omega Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Omega Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
13.0Strong Buy7Odds
Omega Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Omega analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Omega stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Omega Therapeutics, talking to its executives and customers, or listening to Omega conference calls.
Omega Analyst Advice Details
Omega Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Omega Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Omega Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Omega Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Omega Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Omega Therapeutics Trend Analysis

Use this graph to draw trend lines for Omega Therapeutics. You can use it to identify possible trend reversals for Omega Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Omega Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Omega Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Omega Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.0074  , which may suggest that Omega Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2.06, which is the sum of squared deviations for the predicted Omega Therapeutics price change compared to its average price change.

About Omega Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Omega Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Omega Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Omega Therapeutics price pattern first instead of the macroeconomic environment surrounding Omega Therapeutics. By analyzing Omega Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Omega Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Omega Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 (projected)
Graham Number10.336.65.69
Receivables Turnover1.150.440.5

Omega Therapeutics November 25, 2024 Technical Indicators

Most technical analysis of Omega help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Omega from various momentum indicators to cycle indicators. When you analyze Omega charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Omega Therapeutics November 25, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Omega stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Omega Stock analysis

When running Omega Therapeutics' price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years